Back to BlackRock, Inc. BlackRock, Inc.

CYTKCYTK
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in CYTOKINETICS INC

BlackRock, Inc. holds 20.1M shares of CYTK (CYTOKINETICS INC), worth $1.7B as of 2026-Q2. The position was increased (+21.4% shares). CYTK represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$1.7B

Current Shares

20.1M

Total Value Change

+$984.2M

Total Shares Change

+4.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
20.1M
+21.4%
$1.7B0.0%$85.19
38
2026-Q1
Increased
16.5M
+0.9%
$1.1B0.0%$60.72
32
2025-Q4
Increased
16.4M
+5.6%
$1B0.0%$61.37
34
2025-Q3
Decreased
15.5M
-1.0%
$853.3M0.0%$53.89
0
2025-Q2
Increased
15.7M
+0.7%
$518M0.0%$33.16
31
2025-Q1
Increased
15.6M
+0.6%
$625.5M0.0%$43.19
32
2024-Q4
New
15.5M
-
$727.7M0.0%$47.15
44

Other major holders of CYTK: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used